Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-17-001662
Filing Date
2017-02-21
Accepted
2017-02-21 16:42:28
Documents
42
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q1216_americanbrivision.htm 10-Q 265403
2 CERTIFICATION f10q1216ex31i_americanbri.htm EX-31.1 11041
3 CERTIFICATION f10q1216ex31ii_americanbri.htm EX-31.2 11532
4 CERTIFICATION f10q1216ex32i_americanbri.htm EX-32.1 3974
5 CERTIFICATION f10q1216ex32ii_americanbri.htm EX-32.2 4171
  Complete submission text file 0001213900-17-001662.txt   1554124

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE mtoo-20161231.xml EX-101.INS 193467
7 XBRL SCHEMA FILE mtoo-20161231.xsd EX-101.SCH 22684
8 XBRL CALCULATION FILE mtoo-20161231_cal.xml EX-101.CAL 24900
9 XBRL DEFINITION FILE mtoo-20161231_def.xml EX-101.DEF 41214
10 XBRL LABEL FILE mtoo-20161231_lab.xml EX-101.LAB 148948
11 XBRL PRESENTATION FILE mtoo-20161231_pre.xml EX-101.PRE 116723
Mailing Address 11 SAWYERS PEAK DRIVE GOSHEN NY 10924
Business Address 11 SAWYERS PEAK DRIVE GOSHEN NY 10924 845-551-8728
American BriVision (Holding) Corp (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 333-91436 | Film No.: 17625608
SIC: 2834 Pharmaceutical Preparations